Korro Bio, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 11/03/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.4 | $2.3 | $0.0 | — | $0.0 |
| Operating income | -$121.9 | -$91.9 | -$84.5 | — | -$59.0 |
| Net income | -$117.3 | -$83.6 | -$81.2 | — | -$58.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$79.1 | -$78.0 | -$75.1 | — | -$58.8 |
Shares outstanding 14.7M · Free float 33.8%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.